CIK: 0001782539 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 13, 2025
Total Value ($000): $116,921 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ILMN | ILLUMINA INC | 119,196 | $15,928 | 13.6% | $459.88 | -69.0% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 368,665 | $12,686 | 10.8% | $30.00 | +14.5% | COM | 413197104 |
| OCS | OCULIS HOLDING AG | 436,378 | $7,418 | 6.3% | $9.59 | +64.2% | ORDINARY SHARES | H5870P102 |
| — | VERONA PHARMA PLC | 133,040 | $6,178 | 5.3% | $46.44 | — | SPONSORED ADS | 925050106 |
| ZLAB | ZAI LAB LTD | 235,000 | $6,155 | 5.3% | $22.55 | — | ADR | 98887Q104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 125,330 | $5,182 | 4.4% | $31.69 | +31.5% | COM | 604749101 |
| — | MERUS N V | 120,038 | $5,048 | 4.3% | $27.41 | — | COM | N5749R100 |
| GERN | GERON CORP | 1,373,550 | $4,862 | 4.2% | $2.56 | +56.1% | COM | 374163103 |
| INCY | INCYTE CORP | 67,022 | $4,629 | 4.0% | $63.22 | +12.7% | COM | 45337C102 |
| RXRX | RECURSION PHARMACEUTICALS IN | 664,610 | $4,493 | 3.8% | $6.72 | 0.0% | CL A | 75629V104 |
| XENE | XENON PHARMACEUTICALS INC | 106,680 | $4,182 | 3.6% | $18.43 | +124.3% | COM | 98420N105 |
| REPL | REPLIMUNE GROUP INC | 321,746 | $3,896 | 3.3% | $14.85 | -18.2% | COM | 76029N106 |
| — | TOURMALINE BIO INC | 187,090 | $3,794 | 3.2% | $15.58 | — | COM | 89157D105 |
| ONC | BEIGENE LTD | 19,997 | $3,694 | 3.2% | $213.29 | — | SPONSORED ADR | 07725L102 |
| SLNO | SOLENO THERAPEUTICS INC | 79,650 | $3,580 | 3.1% | $48.65 | +6.5% | COM | 834203309 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 11,122 | $3,432 | 2.9% | $242.17 | +16.1% | COM | 558868105 |
| LAB | STANDARD BIOTOOLS INC | 1,883,179 | $3,296 | 2.8% | $2.41 | -22.8% | COM | 34385P108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 49,120 | $2,750 | 2.4% | $27.85 | +98.3% | COM | 76243J105 |
| EXEL | EXELIXIS INC | 64,200 | $2,138 | 1.8% | $23.32 | +39.1% | COM | 30161Q104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 102,984 | $1,890 | 1.6% | $23.42 | -31.1% | COM | 004225108 |
| ASND | ASCENDIS PHARMA A/S | 13,600 | $1,872 | 1.6% | $151.17 | — | SPONSORED ADR | 04351P101 |
| RBRK | RUBRIK INC. | 24,338 | $1,591 | 1.4% | $49.40 | 0.0% | CL A | 781154109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 154,522 | $1,309 | 1.1% | $13.67 | -24.3% | COM | 483497103 |
| KYMR | KYMERA THERAPEUTICS INC | 30,875 | $1,242 | 1.1% | $41.86 | +7.9% | COM | 501575104 |
| BCYC | BICYCLE THERAPEUTICS PLC | 68,943 | $965 | 0.8% | $17.35 | — | SPONSORED ADS | 088786108 |
| TRDA | ENTRADA THERAPEUTICS INC | 49,082 | $849 | 0.7% | $9.39 | — | COM | 29384C108 |
| RVMD | REVOLUTION MEDICINES INC | 19,253 | $842 | 0.7% | $42.57 | +18.6% | COM | 76155X100 |
| CLYM | CLIMB BIO INC | 463,654 | $835 | 0.7% | $7.07 | -48.9% | COM | 28658R106 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $676 | 0.6% | $17.30 | -87.9% | COM CL A | 753018100 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $624 | 0.5% | $15.46 | — | COM | 097702104 |
| — | BOLT PROJS HLDGS INC | 811,952 | $391 | 0.3% | $0.82 | — | COM | 09769B107 |
| ARGX | ARGENX SE | 430 | $264 | 0.2% | $542.08 | — | SPONSORED ADR | 04016X101 |
| DBVT | DBV TECHNOLOGIES S A | 37,095 | $115 | 0.1% | $3.09 | — | SPONSORED ADS | 23306J309 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $70 | 0.1% | $60.98 | -97.5% | COM | 00166B105 |
| AFMDQ | AFFIMED N V | 37,247 | $44 | 0.0% | $5.69 | -50.9% | ORDINARY SHS NEW | N01045207 |